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a  b  s  t  r  a  c  t
Melanin-concentrating  hormone  (MCH)  is a  hypothalamic  peptide  that  plays  a critical  role  in  the  regu-
lation  of food  intake  and  energy  metabolism.  In this  study,  we  investigated  the  potential  role  of  dense
hippocampal  MCH  innervation  in  the  spatially  oriented  food-seeking  component  of feeding  behavior.
Rats  were  trained  for  eight  sessions  to seek  food  buried  in an arena  using  the  working  memory  version
of  the  food-seeking  behavior  (FSB)  task.  The  testing  day  involved  a bilateral  anti-MCH  injection  into  the
hippocampal  formation  followed  by two trials.  The  anti-MCH  injection  did  not  interfere  with the  perfor-
mance  during  the  ﬁrst  trial  on the testing  day,  which  was  similar  to the  training  trials.  However,  during  the
second testing  trial,  when  no  food  was  presented  in  the arena,  the  control  subjects  exhibited  a dramaticpatial memory
orking memory
ippocampus
ood intake
increase  in  the  latency  to  initiate  digging.  Treatment  with  an  anti-MCH  antibody  did  not interfere  with
either  the food-seeking  behavior  or the  spatial  orientation  of  the subjects,  but the  increase  in the  latency
to  start  digging  observed  in  the control  subjects  was  prevented.  These  results  are  discussed  in  terms  of
a potential  MCH-mediated  hippocampal  role  in  the  integration  of  the  sensory  information  necessary  for
re-ingdecision-making  in  the  p
. Introduction
Feeding behavior is a complex temporally organized process
nvolving pre-ingestive, consummatory and post-ingestive mech-
nisms [28]. Distinct neuropeptide systems speciﬁcally contribute
o the control of these different phases of feeding behavior [5]. The
elanin-concentrating hormone (MCH) system plays a key role
n the control of feeding behavior and energy metabolism; how-
ver, the feeding behavior phase in which this peptide acts remains
nknown. The intracerebroventricular administration of MCH
nduces hyperphagia and increases body weight [21,31,48–50]. In
ddition, obese (ob/ob) mice and both fasted rats and mice exhibit
CH  mRNA overexpression [25,48,63]. Furthermore, while MCH
nock-out mice display a hypophagia-related decrease in body
eight associated with increased energy expenditure [57], MCH
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196-9781/© 2016 Elsevier Inc. All rights reserved.estive  component  of  feeding  behavior.
© 2016  Elsevier  Inc.  All  rights  reserved.
receptor (MCH-1R) knock-out mice are lean, albeit hyperphagic
and their leanness is a consequence of hyperactivity and increased
metabolic rate [13,32]. Moreover, the administration of MCH-1R-
speciﬁc antagonists decreases body weight gain [9,56,62].
MCH-expressing neurons are primarily located in lateral
hypothalamic (LHA) and incerto-hypothalamic areas (IHy), sending
out widespread projections along the neuro-axis [8]. Projections
from the arcuate nucleus to MCH  neurons located in the LHA con-
stitute an anatomical substrate underlying the function of MCH  in
food intake regulation [10,17,19,53]. However, LHA and IHy are
integrative centers that inﬂuence a variety of systems and func-
tions but do not act as direct modulators of effector functions.
The areas that are innervated by MCH  neurons do not appear to
be directly associated with hunger. Instead of promoting direct
food ingestion, MCH  neurons seem to affect arousal and locomo-
tor activity, increasing the probability that an animal will ﬁnd food
[6,52]. The distribution of the primary MCH  immunoreactive ﬁbers
is widespread, including the hippocampal formation, prefrontal
cortex, nucleus accumbens shell, medial septal nucleus, pars lat-
eralis of the medial mammillary nucleus, median eminence and
periaqueductal gray matter [8]. Several studies have suggested that
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his peptide is involved in a variety of functions, including arousal,
xploratory behavior, depression, anxiety, reward, sleep homeo-
tasis and memory processing [7–9,12,16,18,23,33,35,36,46,65].
Within the hippocampal formation, the CA3 subﬁeld is densely
nnervated with MCH  immunoreactive ﬁbers [8,30]. In addition,
he three hippocampal subﬁelds, CA1, CA2 and CA3, are among the
egions in the rat brain that most strongly express MCH-1R [51].
aze learning is disrupted by dorsal, but not ventral, hippocam-
al damage [27,58]. Moser and collaborators showed that dorsal
ippocampal lesions, but not equally large ventral lesions, disrupt
he acquisition of the spatial water maze task [39,40]. In addition,
orsal CA1 pyramidal cell loss, which follows transient cerebral
schemia, disrupts spatial learning; interestingly, this deﬁcit has
een directly associated with the degree of cell loss [34,44,66].
ore recently, several studies have demonstrated that the dor-
al hippocampus plays a role in spatial working memory processes
14,15]. Furthermore, the CA3 subﬁeld is critical for the retention
f spatial working memory [11,20,24,26,29,60]. Interestingly, MCH
odulates the activity of hippocampal cells, thus facilitating mem-
ry retention [36,64].
Taken together, this evidence suggests that hippocampal MCH
nnervation might regulate the food-seeking component of feeding
ehavior in locations where food has been previously identiﬁed. To
xamine this hypothesis, the present study investigated the effects
f bilateral topical micro-infusion of anti-MCH antiserum within
he dorsal hippocampal formation on the performance of rats sub-
ected to the food-seeking behavior (FSB) task to evaluate their
patial working memory [59].
. Methods
.1. Subjects
For this study, 11 male Wistar rats, weighing 200–230 g at
he beginning of the experiment, were maintained in individ-
al cages under a 12 h light-dark cycle (lights on at 6 am)  in a
emperature-controlled and acoustically isolated room. All rats
ere food deprived until their weight was reduced to 85% of the
d-lib level and provided unlimited access to water. The food depri-
ation schedule was initiated at four days prior to the habituation
essions (see below), and the body weight of each animal was  mon-
tored daily. The animals were offered a single meal of chow two
ours after daily training. All training and testing sessions were per-
ormed during the light phase of the cycle. All experiments were
erformed in accordance with the Guidelines for the Use of Ani-
als in Neuroscience and Behavioral Research established by the
S National Institutes of Health [42] and approved by the Insti-
ute of Biomedical Sciences, University of São Paulo Committee
or Research and Animal Care (Approved Protocol 89/2010). We
ttempted to minimize the number of rats used, and every effort
as made to ensure that no rat suffered unnecessarily.
.2. Surgery
At least 7 days before initiating the behavioral experiments,
he animals were anesthetized via a subcutaneous injection of
n aqueous solution containing ketamine (5 mg/100 g), xylazine
1 mg/100 g) and acepromazine (0.2 mg/100 g) and then placed
n stereotaxic frames. Then, bilateral implants of guide cannula
22 gauge) aimed at the dorsal CA3 subﬁeld of the hippocam-
us were introduced. The stereotaxic coordinates, based on the
axinos & Watson’s rat brain atlas [45], were −3.6 (anteropos-
erior), ±3.3 (mediolateral), −3.1 (dorsoventral) mm.  During the
ost-surgical time and before the beginning of the behavioral pro-
edures, the rats were handled daily (once per day), and the surgical6 (2016) 130–138 131
area was cleaned and disinfected with iodopovidine solution. The
rats exposed to handling were later subjected to micro-infusion to
habituate the animals to the procedure and prevent the implanted
guide cannula from becoming obstructed, which involved the intro-
duction of a needle with the same length as the guide cannula.
2.3. Apparatus
The test apparatus [59] used in the FSB task was a round,
150 × 90 cm ﬁberglass arena, ﬁlled to a depth of 5 cm with wash-
able dark blue granulated low-density polyethylene. To reduce the
importance of olfactory cues associated with speciﬁc locations in
the arena, 100 g of Froot LoopsTM cereal and 100 g of laboratory
chow were crushed and mixed with the granulated polyethylene.
A movable 20 × 20 × 20 cm opaque acrylic starting box, ﬁlled to a
depth of 5 cm with granulated low-density polyethylene on the
ﬂoor and a guillotine door in one of its walls, was used as a tem-
porary cage in which the animal was housed from the beginning of
the session until two  hours after the daily task, when they received
the daily amount of lab chow in their home cages. The same mov-
able box was  used to individually transfer the animals from their
home cages into the arena, minimizing the stress of transfer and
habituating the animals to the granulated polyethylene ﬂoor. The
arena was  located in a sound-attenuated room with high-contrast
ﬁgures on the walls. A DVD camera (Sony Handycam Digital DCR-
DVD203) equipped with a 0.6 × wide-angle conversion lens was
positioned approximately 280 cm above the center of the arena and
used to register the sessions. In addition, the DVD camera was con-
nected to a video monitor for the continuous monitoring of the
session. Thus, the experimenter could intervene rapidly when the
rat obtained food or when the time limit for ﬁnding food elapsed.
For descriptive data analysis, the arena was  imaginarily divided into
four equal-area quadrants. The quadrants were separated along
lines that intersected the edge of the arena at arbitrary cardinal
starting locations, referred to as north, south, east and west. An
imaginary area measuring 25 cm in diameter (the target counter)
was located at the center of each quadrant, where Petri dishes
containing food were offered (see below). These training counters
provided more speciﬁc indices of the spatial location.
Petri dish bottoms 60 mm in diameter, containing 1 g of food (6
pieces of lab chow) were covered with a single layer of ParaﬁlmTM
to avoid olfactory guidance. The external surface of the ParaﬁlmTM
did not contact the food.
2.4. FSB task and topical micro-infusion of anti-MCH
The FSB task has been fully described elsewhere [59] and
involves a dry-land maze version of the Morris Water Maze [37,38],
modiﬁed to speciﬁcally examine food-seeking behavior and spa-
tial working memory without olfactory cues. As the task aims to
analyze the spatial memory component of the food-seeking, olfac-
tory cues were removed because olfaction is a preponderant cue for
rodents and could be used to locate the food. The subjects received
85% of the ad-lib chow level. Four days after the beginning of the
food-deprivation, the animals were exposed to successive phases
involving (1) two  sessions of habituation to the apparatus, (2) two
sessions of pretraining for the identiﬁcation of Petri dishes con-
taining food, (3) eight sessions of training in a working memory
version of the task and (4) one session of testing involving the injec-
tion of anti-MCH (see below). A session was composed by daily
trials. Before each session, the subjects were exposed to the micro-
infusion handling procedure, as described above; for habituation,
pre-training and training phases, no material was  injected. The sub-
jects were subsequently placed in an individual starting box for
approximately 10 min  before the beginning of the trials. The ani-
mals were transferred to the arena using the movable starting box,
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hich was inserted in variable locations from trial to trial close to
he arena wall, with the guillotine door oriented towards the arena
enter. Subsequently, the guillotine door was opened to release the
nimal.
The habituation phase involved two sessions, with one session
er day and two trials per session. In each trial, four Petri dishes
ere offered on the surface of the granulated polyethylene in the
rena in the center of each quadrant. The animal was allowed to
reely explore the arena for 3 min  after its initial release from the
tarting box. If the subject either did not ﬁnd or did not unseal
ny of the Petri dishes within 3 min, the experimenter manually
uided the animal towards one of the Petri dishes and opened
he ParaﬁlmTM seal to allow the subject to obtain a pellet of lab
how. The animal was subsequently guided towards the starting
ox, where it remained for 20 min  until the next trial.
The pre-training phase involved two sessions, with one session
er day and three trials per session. Each trial was similar to those
f the habituation phase, except that the Petri dishes were progres-
ively buried in the granulated polyethylene in the arena during all
rials and sessions.
The training phase involved eight sessions, with one session per
ay and three trials per session. Each trial was similar to that of
he pre-training phase, except that only one Petri dish containing
ood was buried in the center of one of the quadrants. The quad-
ant containing the buried Petri dish varied randomly from session
o session but was kept constant for the trials within a session to
xamine working memory. The trial ended when the subject either
ug out and opened the Petri dish or carried the dish to the starting
ox. When the Petri dish was not found within 3 min after the initial
elease of the rat from the starting box, the subject was manually
uided to the location of the dish, and the experimenter unburied
he Petri dish to allow the subject to open it. If the animal did not
hen return to the starting box on its own, manual guidance was
sed to direct the animal back to the starting box, where it remained
or 20 min  until the next trial. Subsequently, a novel Petri dish con-
aining food was buried in the same location for the next trial. The
ntertrial interval lasted 20 min.
The testing phase involved one session with two trials. Each test-
ng trial was similar to that of the training phase, except that in the
econd testing trial, no food was placed within the Petri dish buried
n the arena (Probe test). Ten min  before initiating the ﬁrst testing
rial, the subjects were individually placed in waiting cages (the
ovable starting boxes) and bilaterally micro-infused with either
 l of the anti-MCH antibody (1:1, N = 7, anti-MCH group) or 1 l
f 0.9% saline (N = 4, control group), at an infusion rate of 1 l per
inute. For microinjection, a 28-gauge infusion cannula that was
 mm longer than the guide cannula was inserted. The infusion can-
ula was connected to a polyethylene tube for remote injection
sing a Hamilton microsyringe and was removed from the guide
annula 5 min  after the microinjection. The subjects were then held
or another 5 min  prior to initiating the session. The anti-MCH used
n this study was a generous gift from Dr. Wylie W.  Vale (in memo-
iam) and Joan Vaughan from The Salk Institute (La Jolla, CA, USA).
his antiserum (PBL #234) was raised in rabbit and it was  prepared
gainst synthetic peptide conjugated to human -globulins via glu-
araldehyde. Previous speciﬁcity tests showed that the staining for
CH  was completely abolished by preincubation of the antiserum
ith micromolar concentrations of the peptide, and the staining
ith this antiserum was colocalized with in situ hybridization for
he mRNA for the same protein [8,41,54].
.5. HistologyAt the end of the behavioral procedures, the animals were
nesthetized with a lethal dose of 35% chloral hydrate (1 ml,
.p.) and perfused via the ascending aorta with cold 0.9% saline6 (2016) 130–138
(100 ml), followed by 4% formaldehyde ﬁxative in borate buffer,
pH 9.5, at 4 ◦C (800–1000 ml). Immediately after perfusion, the
brains of the animals were removed, postﬁxed overnight in the
same ﬁxative (supplemented with 20% sucrose) and then trans-
ferred to 20% sucrose in potassium phosphate-buffered saline
(KPBS), pH 7.4. Series of 30-m coronal sections (1:5 series)
were cut on a freezing microtome and stored at −30 ◦C in
antifreeze buffer. For reference purposes, one series from each
animal was  mounted on gelatin-coated slides, stained with
thionin and coverslipped. The slides were examined under a light
microscope to determine the placement of the cannula. Only
those animals in which the tip of the injection cannula was
positioned correctly were considered in the statistical evaluation
of the results.
2.6. Analysis of the anti-MCH diffusion
Series of sections of all anti-MCH and control animals were sub-
mitted to a standard peroxidase reaction in order to analyze the
diffusion of the antiserum injected in the hippocampus (anti-MCH
group) or its absence (control group). Sections were treated with
0.3% peroxide in KPBS for 15 min  and then incubated in biotiny-
lated secondary antibody made in donkey anti-rabbit (Jackson
Labs, 1:800) and avidin–biotin complex (Vector, 1:333), both for
1 h. Next, the sections were subjected to a peroxidase reaction
using diaminobenzidine tetrahydrochloride (DAB, Sigma, 0,02%)
as a chromogen solution, nickel sulfate 2,5% and 0,02% hydrogen
peroxide dissolved in sodium acetate buffer. The reaction was ter-
minated after 2–4 min  with successive rinses of sodium acetate
buffer and KPBS. Sections were mounted on gelatin-coated slides,
dehydrated, cleared in xylene and coverslipped.
2.7. Data analysis
For each trial, in both the training and testing sessions, we mea-
sured (1) the total amount of time the animal spent locating the
Petri dish after release from the starting box (latency); (2) the total
distance traveled (path length); (3) the latency until the ﬁrst entry
of the rat’s head into the quadrant where the Petri dish was buried
(target quadrant); (4) the latency until the ﬁrst entry of the rat’s
head into the target counter after the ﬁrst entry into the target
quadrant; and (5) the latency to dig in the correct location after the
ﬁrst entry into the target counter. ANY-mazeTM behavioral analy-
sis software (Stoelting, Wood Dale, IL, USA) was  used to score the
trial data. Only animals presented adequate cannula position were
included in the statistical analysis.
The training sessions were identical for all subjects, and until the
end of this phase, there were no distinct group treatments. During
the testing session, however, some of the subjects were injected
with the anti-MCH antibody prior to testing, while other subjects
were injected with saline, thus generating two  groups. Neverthe-
less, the training data analysis was  run retrospectively, considering
the existence of these two groups. Hence, potential differences
occurring during testing, but not during training, could reﬂect the
drug treatment rather than pre-existing group differences.
The behavioral scores were subjected to repeated measures
analysis of variance (ANOVA), using the groups as the between-
subject variables and days (sessions) and the trials as the
within-subject variables (SAS Institute, Inc., Cary, NC). Separate
ANOVAs for each measure were run for both the training and testing
scores.
3. Results3.1. Histology
Light microscopic evaluation of Nissl-stained sections from
the rat brains indicated that the tip of the cannula was  posi-
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cig. 1. A representative brightﬁeld photomicrograph of a Nissl-stained section obtai
A1,  CA1 subﬁeld of the hippocampus; CA2, CA2 subﬁeld of the hippocampus; CA3
ioned correctly in the CA3 subﬁeld of the hippocampus, bilaterally
Fig. 1).
.2. Antiserum diffusion
Light microscopic analysis of the sections submitted to the per-
xidase reaction to observe the diffusion of the antiserum around
he cannula showed that the injected volume of anti-MCH was
nough to diffuse to the CA3 region (Fig. 2A–F). CA2 may  be received
 limited amount of the antiserum, although most of the CA2
egion was lesioned by the passage of the guide cannula in all
nimals. This analysis also suggested that the antiserum seems to
e absorbed at different speeds among the animals, as revealed
y different immunoreactivity areas. An anti-MCH animal showed
eak labeling (Fig. 2B) and other one a strong labeling (Fig. 2C)
aking the establishment of diffusion boundaries difﬁcult. The
hotomicrograph of an anti-MCH animal was omitted for aesthet-
cal purposes. All control animals that were injected with saline
resented absence of immunoreactivity.
.3. FSB task training
The acquisition of the food-seeking task was assessed by requir-
ng the rats (N = 11) to learn a novel food location every day,
n a matching to place procedure with three trials per day and
n inter-trial interval of 20 min. The animals exhibited a general
mprovement in performance during training, as revealed by sig-
iﬁcant day effects for latency (F7,63 = 14.02, P < 0.0001), path length
F7,63 = 11.79, P < 0.0001), latency until the ﬁrst entry into the tar-
et quadrant (F7,63 = 2.85, P < 0.02), latency until the ﬁrst entry into
he target counter after the ﬁrst entry into the target quadrant
F7,63 = 2.60, P < 0.03) and latency to dig in the correct place after the
rst entry into the target counter (F7,63 = 7.10, P < 0.0001). Indeed,
ig. 3 shows that there was a general decrement in these scores as
he subjects learned to manage the basic requirements of the FSB
ask.
Repeated measures ANOVA also revealed (1) signiﬁcant Trial
ffects for the latency (F2,18 = 6.17, P < 0.01) and the latency until
he ﬁrst entry into the target counter (F2,18 = 6.66, P < 0.01); (2)
lightly signiﬁcant Trial effects for the path length (F2,18 = 3.51,
 = 0.0518) and the latency to the ﬁrst entry into the target quadrant
F2,18 = 3.51, P = 0.0516); and (3) signiﬁcant day × trial interaction
ffects for the latency to the ﬁrst entry into the target quadrant
F14,126 = 3.47, P < 0.001). Indeed, Fig. 3 shows that performance,
xpressed as the latency, path length and latency to the ﬁrst
ntry into the target counter, generally decreased during the tri-
ls, indicating that the animals are capable of storing information
oncerning the food location obtained from the ﬁrst trial in theirm a rat showing gliosis of the cannula implants in the hippocampus. Abbreviations:
ubﬁeld of the hippocampus; cc, corpus callosum; DG, dentate gyrus. Bar: 500 m.
working memories for subsequent application in the remaining
trials.
As expected, ANOVA revealed no signiﬁcant main group,
group × trial, group × day or group × trial × day interaction effects
for any of the training scores (Fig. 3). This result suggests that the
performance of the subjects in each of the groups did not differ
prior to the administration of anti-MCH, ruling out the possibil-
ity that differences in the testing scores reﬂect pre-existing group
differences.
3.4. Testing
In the testing session, the subjects received a bilateral intra-
hippocampus injection of either an anti-MCH antibody or saline
10 min  before the testing session. In the ﬁrst trial, a sealed Petri dish
containing food was buried in the center of one of the quadrants.
In the second trial, the sealed Petri dish was empty (probe test).
The ANOVA revealed (1) a signiﬁcant main group effect for the
latency (F1,9 = 7.48, P < 0.03) (Fig. 3A) and path length (F1,9 = 7.83,
P < 0.03) (Fig. 3B); (2) a signiﬁcant main trial effect for the latency
(F1,9 = 12.94, P < 0.006), path length (F1,9 = 13.84, P < 0.005) and
latency to dig in the correct place after the ﬁrst entry into the tar-
get counter (F1,9 = 15.27, P < 0.004) (Fig. 3E); and (3) a signiﬁcant
group × trial interaction effect for the latency (F1,9 = 6.56, P < 0.04),
path length (F1,9 = 5.12, P < 0.05) and latency to dig (F1,9 = 9.89,
P < 0.02). In addition, ANOVA revealed a slightly signiﬁcant main
group effect for the latency to dig (F1,9 = 4.98, P = 0.0525). However,
ANOVA revealed no signiﬁcant differences for the latency until the
ﬁrst entry into the target quadrant (Fig. 3C) or the latency until ﬁrst
entry into the target counter after the ﬁrst entry into the target
quadrant (Fig. 3D) (F1,9 = 0.17–1.71, P > 0.5). As shown in Fig. 3, the
anti-MCH and control subjects were equally capable of ﬁnding the
location where the food was buried in the ﬁrst trial. However, in the
second trial, when the sealed Petri dish was empty, although the
subjects injected with anti-MCH within the hippocampus reached
the target location at the same time as the control subjects (Fig. 3C
and D), these animals took longer to dig (Fig. 3E), as reﬂected in the
total latency (Fig. 3A) and path length (Fig. 3B).
4. Discussion
In this study, we  investigated the effect of interference with
hippocampal MCH  neurotransmission on spatially oriented food-
seeking behavior. The effects of bilateral anti-MCH microinjection
into the dorsal hippocampal formation were investigated in rats
exposed to an appetitive task (the FSB task), adapted to evaluate
the contribution of the spatial memory to food-seeking behavior
[59]. Animals previously trained in a working memory version of
134 L.V. Sita et al. / Peptides 76 (2016) 130–138
Fig. 2. Antiserum diffusion in the hippocampus. Brightﬁeld unilateral photomicrograph of sections from bilateral injection of anti-MCH (A–F) and saline injected animals
( tion (
i  subﬁ
ﬁ
t
t
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i
s
m
t
tG–J)  submitted to peroxidase protocol showing an immunostained anti-MCH injec
njected with saline. Abbreviations: CA1, CA1 subﬁeld of the hippocampus; CA2, CA2
,  ﬁmbria of the hippocampus. Bar: 500 m.
he FSB task were microinjected with anti-MCH 10 min  before the
esting session to evaluate the effects of anti-MCH on (1) forag-
ng for food in one of four previously rewarded locations, i.e., the
enter of each of the quadrants of the arena; (2) the acquisition of
nformation concerning the location of food in that speciﬁc testing
ession; and (3) the maintenance of this information in the working
emory for at least 20 min  for subsequent use in a second testingrial.
In order to properly evaluate the effect of the antiserum into
he hippocampus, cannulas were placed in the CA3 subﬁeld of theanti-MCH animals, arrows) or the absence of immunoreactivity in control animals
eld of the hippocampus; CA3, CA3 subﬁeld of the hippocampus; DG,  dentate gyrus;
dorsal hippocampus, since the CA3 subﬁeld is denser innervated
with MCH  immunoreactive ﬁbers than CA1 or CA2 subﬁelds [8,30].
We analyzed only animals with cannulas properly localized in this
subﬁeld. However, the postmortem analysis of the antiserum dif-
fusion was unable to ensure that the diffusion was  restricted to the
CA3. We  considered that the anti-MCH inactivated primarily the
CA3 MCH  innervation, but also promoted an uncertain inactivation
in adjacent areas. It is also important to note that the guide can-
nula caused extensive damage in CA2 subﬁeld. The histological and
immunohistochemical analysis suggest that the behavioral effect
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Fig. 3. Performance of the rats during the 8 days of training in a working memory version of the food-seeking behavior (FSB) task, with 3 trials per day, and along with
2  trials on a single testing day before which the rats received a single bilateral injection of either anti-MCH (open squares) or saline (black circles). The treatments were
implemented only before the testing session. Therefore, for purposes of representation, the analysis of the training data in the separate groups is only retrospective. See main
text  for detailed explanations. (A) Latency to locate the food. (B) Mean distance traveled (path length) to locate the food. (C) Latency until ﬁrst entry into the target quadrant.
(D)  Latency until the ﬁrst entry into the target counter after the ﬁrst entry into the target quadrant. (E) Latency to dig in the correct place after the ﬁrst entry into the target
counter. The data are reported as mean scores ±SEM.
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escribed in this paper is a result of the disfunction of the dorsal
ippocampal formation.
Four different latency-related measures were determined to
roperly evaluate performance. In each trial, we measured the stan-
ard latency to locate the Petri dish after release from the starting
ox, the latency until the ﬁrst entry into the target quadrant where
he Petri dish was buried, the latency until the ﬁrst entry into the
arget counter after the ﬁrst entry into the target quadrant, and the
atency to dig in the correct place after the ﬁrst entry into the target
ounter. Decomposition of the general latency score into subcom-
onents facilitated a detailed evaluation of performance. That is,
hile the latencies until the ﬁrst entry into the target quadrant
nd target counter represent speciﬁc indices of spatial orientation,
eﬂecting the spatial memory of the subjects, the latency to dig
n the correct location after the ﬁrst entry into the target counter
eﬂects either the motivation or the certainty of the subject relative
o the location of food.
The results obtained in the present study showed that injecting
he MCH  antibody into the dorsal hippocampus did not interfere
ith food foraging in previously rewarded locations based on an
llocentric spatial cognitive map, as food seeking during the ﬁrst
esting trial was not disturbed in the anti-MCH-injected subjects
ompared to the control subjects. In the second testing trial, con-
ucted 20 min  after the ﬁrst testing trial, an empty sealed Petri dish
as present at the previously rewarded location. There were no
igniﬁcant differences between the anti-MCH and control subjects
egarding the ﬁnding of the correct location, as reﬂected in both the
atency to the ﬁrst entry into the target quadrant and the latency
o the ﬁrst entry into the target counter. Surprisingly, however,
he control subjects exhibited longer latencies to dig in the correct
ocation after the initial entry into the target counter compared to
nti-MCH subjects, which promptly dug in the correct place. As a
onsequence of the increase in the latency to dig, the control sub-
ects also exhibited longer general latencies and path lengths than
nti-MCH injected subjects.
The decomposition of the latency measure applied in the present
tudy revealed that the anti-MCH antibody did not affect spatial
earning. The increase in latency to start digging in the correct
ocation by the control subjects in the second testing trial relative
o both (1) the corresponding scores by anti-MCH injected sub-
ects and (2) their own latencies to start digging in the ﬁrst testing
rial is quite surprising and seems to be related to absence of food.
araﬁlmTM sealing seems to avoid the animals to use olfactory cues
o locate the petri dish, but didnı´t prevent them to recognize the
resence or absence of food after locating the Petri dish. As revealed
y the saline-injected group, food-originated olfactory cues are
equired to stimulate the digging behavior in this behavioral task.
he injection of anti-MCH could have altered the attentional pro-
ess necessary to the modulation of the motor behavior and the
nimals did not stop the behavior of searching for food, even in
ront of the absence of food, as expected.
It has been suggested that the hippocampus plays a pivotal
ole in detecting conﬂict situations through interrupting ongo-
ng behavior and increasing the level of arousal and attention to
nhance the gathering of information [22]. The hippocampus func-
ions as a context analyzer that modulates adaptive motor activity
n response to particular sensory events in the environment [43].
CH innervation of the hippocampus could be associated to this
ippocampal role in detecting conﬂict situation, since the ani-
als injected with anti-MCH did not adapt their behavior in a test
nvolving an unexpected absence of food. Adams et al. [3] showed
hat MCH  knockout mice exhibit impaired food-seeking behav-
or associated with normal levels of exploratory activity and the
uthors concluded that the MCH  played a role in regulating sensory
ntegration from olfactory pathways. Besides, Adamantidis et al.
2] described that MCH-1R knockout mice present learning and6 (2016) 130–138
memory impairments, probably secondary to their hyperactivity
and their alterations of NMDA receptor function.
According to Scharfman [55] the CA3 subﬁeld receives inputs
from a variety of sources, and may  be an “entry point” to hippocam-
pus that receives information which needs to be “broadcasted”.
Since hippocampus receives indirect olfactory afferents through
the perforant path (entorhinal cortex projections to dentate gyrus
and CA3 subﬁeld), the anti-MCH antibody could have prevented
the integration of the olfactory information in the decision-making
processes. This integratory function lies on the fact that the per-
forant path terminals in the CA3 subﬁeld are mainly located in the
stratum lacunosum-moleculare [4]. where MCH  terminals are also
presented [8].
Taking together, our data suggest that MCH  hippocampal inner-
vation is associated to the hippocampal role in detecting potential
conﬂicts that might occur during normal exploratory activity,
which is based on sensory integration. Antagonizing this effect
through the anti-MCH local injection disturbed the integration of
olfactory information and prevented the animals to realize the
absence of food as control animals did.
Concluding, lateral hypothalamic area MCH-containing cells
and the broadly distribution of such terminals are in the position to
subserve the control of motivated behaviors, memory and learning
[1,61]. The widespread distribution of MCH  suggests a role for MCH
in mammals, i.e., a function in generalized arousal and sensorimo-
tor integration [8], which can, in turn, play a role in information
gathering. Although our current knowledge regarding MCH  sug-
gests that this peptide is a critical hypothalamic regulator of energy
homeostasis, affecting both feeding behavior and energy expen-
diture [47], it is also reasonable to consider that somatosensory
information might converge on MCH  cells that mediate diffuse
activational functions, such as feeding [53]. Taking into account
that feeding behavior includes different categories of temporally
distinct behaviors, i.e., pre-ingestive (food-seeking) and consum-
matory mechanisms [5], the results obtained in the present study
suggest that MCH  terminals in the dorsal hippocampus might play
a role in the integration of the sensory information that is necessary
for the decision making involved in the pre-ingestive component
of feeding behavior.
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